Movano (MOVE) Expected to Post Quarterly Earnings on Thursday

Movano (NASDAQ:MOVE) is anticipated to release its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect the company to post earnings of ($3.1664) per share and revenue of $6.71 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Tuesday, August 18, 2026 at 9:30 AM ET.

Movano (NASDAQ:MOVE) last issued its quarterly earnings data on Tuesday, May 19th. The technology company reported ($3.13) EPS for the quarter, missing analysts’ consensus estimates of ($2.65) by ($0.48). The company had revenue of $0.51 million for the quarter, compared to the consensus estimate of $7.62 million.

Movano Stock Down 9.4%

Movano stock opened at $11.74 on Tuesday. The business has a fifty day moving average of $16.77 and a two-hundred day moving average of $15.68. The company has a quick ratio of 2.04, a current ratio of 2.14 and a debt-to-equity ratio of 4.28. The firm has a market cap of $324.49 million, a P/E ratio of -0.85 and a beta of 0.88. Movano has a twelve month low of $3.44 and a twelve month high of $26.72.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Movano currently has an average rating of “Sell”.

Hedge Funds Weigh In On Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new stake in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano as of its most recent SEC filing. Institutional investors and hedge funds own 16.64% of the company’s stock.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Negative Sentiment: Investor concerns may still be tied to Movano’s most recent quarterly results, which showed a substantial earnings miss and revenue of just $0.51 million versus the $7.63 million analyst consensus. The company also reported a loss of $3.13 per share, wider than the expected $2.65 loss.
• Negative Sentiment: Movano remains an unprofitable, small-cap technology company, with a negative price-to-earnings ratio and shares trading below both their 50-day and 200-day moving averages—conditions that can reinforce selling pressure and increase volatility.
• Neutral Sentiment: The company’s liquidity ratios are relatively solid, with a quick ratio of 2.04 and current ratio of 2.14, but the provided information does not include a new financing, partnership, product, regulatory, or clinical update that could offset the recent concerns.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.